ArticleInfection2026
Cardiac injury in children with severe hand, foot and mouth disease: risk factors and clinical outcomes.
Article in Infection, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo determine the risk factors and clinical outcomes of cardiac injury in pediatric patients with severe hand, foot, and mouth disease (HFMD).
methodsWe conducted a multicenter retrospective study at two tertiary children's hospitals in southern Vietnam, including hospitalized patients with severe HFMD and suspected cardiovascular complications. Cardiac injury was identified according to cardiac enzyme results and findings from electrocardiography and echocardiography. Univariable and multivariable logistic regression analyses were used to identify risk factors associated with cardiac injury.
resultsA total of 395 patients were included, with a male predominance, and 96.5% were younger than 36 months. Typical skin rash and herpangina remained the most common clinical manifestations. Intensive care unit admission was required in 72.2% of cases, and 50.9% required endotracheal intubation with mechanical ventilation. Cardiac injury was identified in 7.3% (29/395) of severe HFMD cases with suspected cardiovascular complications. Fever ≥ 39 °C (aOR 10.5, 95% CI 3.4-32.6, p < 0.001), C-reactive protein > 20 mg/L (aOR 3.3, 95% CI 1.3-8.4, p = 0.012), and aspartate aminotransferase > 40 U/L (aOR 4.1, 95% CI 1.7-9.8, p = 0.002) were independent risk factors for cardiac injury. Patients with cardiac injury had higher mortality, longer hospital stays, and a greater incidence of neurological sequelae compared with those without cardiac injury.
conclusionsCardiac injury in pediatric patients with severe HFMD is associated with adverse clinical outcomes, underscoring the need for early risk stratification and comprehensive cardiac assessment.
Indexed as
Identifiers
42867602What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.